Ouwehand WH - Search Results

1

Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors.

Kaptoge S, Di Angelantonio E, Moore C, Walker M, Armitage J, Ouwehand WH, Roberts DJ, Danesh J, Thompson SG; INTERVAL Trial Group. Kaptoge S, et al. Among authors: ouwehand wh. Lancet Haematol. 2019 Oct;6(10):e510-e520. doi: 10.1016/S2352-3026(19)30106-1. Epub 2019 Aug 2. Lancet Haematol. 2019. PMID: 31383583 Free PMC article. Clinical Trial.

2

Molecular biology for platelet alloantigen typing.

Williamson LM, Bruce D, Lubenko A, Chana HJ, Ouwehand WH. Williamson LM, et al. Among authors: ouwehand wh. Transfus Med. 1992 Dec;2(4):255-64. doi: 10.1111/j.1365-3148.1992.tb00167.x. Transfus Med. 1992. PMID: 1364073 Review.

3

Novel diagnostic and therapeutic strategies with genetically engineered human antibodies.

Ouwehand WH, Watkins N. Ouwehand WH, et al. Vox Sang. 1998;74 Suppl 2:223-32. doi: 10.1111/j.1423-0410.1998.tb05424.x. Vox Sang. 1998. PMID: 9704449 Review.

4

Rapid phenotyping of HPA-1a using either diabody-based hemagglutination or recombinant IgG1-based assays.

Watkins NA, Armour KL, Smethurst PA, Metcalfe P, Scott ML, Hughes DL, Smith GA, Williamson LM, Clark MR, Ouwehand WH. Watkins NA, et al. Among authors: ouwehand wh. Transfusion. 1999 Jul;39(7):781-9. doi: 10.1046/j.1537-2995.1999.39070781.x. Transfusion. 1999. PMID: 10413288

5

A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a.

Garner SF, Smethurst PA, Merieux Y, Aeby C, Smith G, Armour KL, Scott ML, Williamson LM, Metcalfe P, Goodall AH, Clark MR, Rigal D, Schawaller M, Ouwehand WH. Garner SF, et al. Among authors: ouwehand wh. Br J Haematol. 2000 Feb;108(2):440-7. doi: 10.1046/j.1365-2141.2000.01839.x. Br J Haematol. 2000. PMID: 10691879 Free article.

6

Introduction to antibody engineering and phage display.

Watkins NA, Ouwehand WH. Watkins NA, et al. Among authors: ouwehand wh. Vox Sang. 2000;78(2):72-9. doi: 10.1159/000031154. Vox Sang. 2000. PMID: 10765141 Review.

7

The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library.

Watkins NA, Brown C, Hurd C, Navarrete C, Ouwehand WH. Watkins NA, et al. Among authors: ouwehand wh. Tissue Antigens. 2000 Mar;55(3):219-28. doi: 10.1034/j.1399-0039.2000.550305.x. Tissue Antigens. 2000. PMID: 10777097

8

Platelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient.

Watkins NA, Smethurst PA, Allen D, Smith GA, Ouwehand WH. Watkins NA, et al. Among authors: ouwehand wh. Br J Haematol. 2002 Mar;116(3):677-85. doi: 10.1046/j.0007-1048.2001.03301.x. Br J Haematol. 2002. PMID: 11849233 Free article.

9

The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression.

Joutsi-Korhonen L, Smethurst PA, Rankin A, Gray E, IJsseldijk M, Onley CM, Watkins NA, Williamson LM, Goodall AH, de Groot PG, Farndale RW, Ouwehand WH. Joutsi-Korhonen L, et al. Among authors: ouwehand wh. Blood. 2003 Jun 1;101(11):4372-9. doi: 10.1182/blood-2002-08-2591. Epub 2003 Jan 30. Blood. 2003. PMID: 12560230 Free article.

10

The effect of recombinant IgG antibodies against the leucine-33 form of the platelet beta3 integrin (HPA-1a) on platelet function.

Joutsi-Korhonen L, Preston S, Smethurst PA, Ijsseldijk M, Schaffner-Reckinger E, Armour KL, Watkins NA, Clark MR, de Groot PG, Farndale RW, Ouwehand WH, Williamson LM. Joutsi-Korhonen L, et al. Among authors: ouwehand wh. Thromb Haemost. 2004 Apr;91(4):743-54. doi: 10.1160/TH03-07-0484. Thromb Haemost. 2004. PMID: 15045136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page